Fundz

T Rex Holdings reported raising $42.3 Million in an initial SEC Form D filing, from an offering of $85 Million

PUBLIC · TRXBNov 26, 2024$42.3M of $85M raised

Amount Raised

$42.3 Million

$42.3 Million sold, per SEC Form D (first sale Nov 7, 2024)

Round Type

Venture

South San FranciscoBiotechnologyHealth CareTherapeutics

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as TRex Bio that raised within 45 days of this round, from Fundz verified event records.

  • Phio Pharmaceuticals raised $55K (Seed) on December 20, 2024.
  • Borealis Biosciences raised $30M (Series A) on December 19, 2024.
  • Akamis Bio raised $60M (Series A) on December 17, 2024.
  • Promise Bio raised $8.3M (Seed) on December 16, 2024.
  • BioSapien raised $5.5M (Series A) on December 13, 2024.
  • Noema Pharma raised $147M (Series B) on December 11, 2024.

Who to call at TRex Bio, and when

A new round usually means TRex Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day TRex Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TRex Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TRex Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TRex Bio

Location

South San Francisco, California, United States

About

TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases. Our powerful ‘deep biology’ discovery engine maps human tissue Treg behavior to disease processes, allowing us to identify and characterize novel targets for therapeutic intervention. Leveraging this platform, we are building a broad portfolio of novel therapies that modulate the immune system to restore human tissue immune homeostasis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TRex Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for TRex Bio's next move

See what Strategic adds

TRex Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.